NDAQ
59
-3
CNX
71
2
EMC
45
3
EXC
54
-2
AEP
62
-4
PBI
60
2
BAX
38
-4
EXPD
54
7
DFS
56
2
LMT
45
-4
COP
50
3
ORLY
62
-2
DNB
54
-4
L
60
2
KIM
51
-3
FRT
43
-15
DUK
64
-5
CME
59
-2
CL
59
-2
GOOG
61
2
NDAQ
59
-3
CNX
71
2
EMC
45
3
EXC
54
-2
AEP
62
-4
PBI
60
2
BAX
38
-4
EXPD
54
7
DFS
56
2
LMT
45
-4
COP
50
3
ORLY
62
-2
DNB
54
-4
L
60
2
KIM
51
-3
FRT
43
-15
DUK
64
-5
CME
59
-2
CL
59
-2
GOOG
61
2
Financhill
Back

Tarsus Pharmaceuticals Quote, Financials, Valuation and Earnings

32,481% Growth? Meet Mode Mobile's "EarnPhone"

This is a paid advertisement for Mode Mobile Regulation A offering. Please read the offering circular and related risks at invest.modemobile.com.
Buy
58

TARS
Tarsus Pharmaceuticals

Last Price:
32.54
Seasonality Move:
3.41%

7 Day Trial

ALL ACCESS PASS

$ 7

How to Profit From "America's Earnings" Reports

New Trade Goes LIVE THIS TUESDAY at 2 pm

Tarsus Pharmaceuticals Price Quote

$32.54
+1.49 (+4.8%)
(Updated: September 18, 2024 at 6:55 PM ET)

Tarsus Pharmaceuticals Key Stats

Buy
58
Tarsus Pharmaceuticals (TARS) is a Buy
Day range:
$30.23 - $32.28
52-week range:
$12.57 - $42.50
Dividend yield:
0%
P/E ratio:
0.00
P/S ratio:
12.76
P/B ratio:
4.68%
Volume:
506.8K
Avg. volume:
795.8K
1-year change:
92.38%
Market cap:
$1.2B
Revenue:
$17.4M
EPS:
$-4.48

How Much Does Tarsus Pharmaceuticals Make?

Is Tarsus Pharmaceuticals Growing As A Company?

Data Unavailable

Tarsus Pharmaceuticals Stock Price Performance

What Is Tarsus Pharmaceuticals 52-Week High & Low?

Tarsus Pharmaceuticals Price To Free Cash Flow

Data Unavailable

Is It Risky To Buy Tarsus Pharmaceuticals?

Is Tarsus Pharmaceuticals Cash Flow Positive?

  • What Is TARS Cash Flow From Operations?
    Cash flow from operations (TTM) is -$123.9M
  • What Is Tarsus Pharmaceuticals’s Cash Flow From Financing?
    Cash flow from financing (TTM) is $275.7M
  • What Is Tarsus Pharmaceuticals’s Cash Flow From Investing?
    Cash flow from investing (TTM) is -$77.5M

Tarsus Pharmaceuticals Return On Invested Capital

  • Is Management Doing A Good Job?
    TARS return on invested capital is -59.01%
  • What Is Tarsus Pharmaceuticals Return On Assets?
    ROA measures how assets are converting to revenues and is -51.79%
  • What Is TARS Return On Equity?
    ROE is a measure of profitability and is -69.1%

Tarsus Pharmaceuticals Earnings Date & Stock Price

Tarsus Pharmaceuticals Competitors

Tarsus Pharmaceuticals Dividend Yield

Tarsus Pharmaceuticals Analyst Estimates

YoY Growth Past Surprise
EPS: 0% -3.8%
Revenue: 0% 27.35%

Analyst Recommendations

Buy Recommendations: 6
Hold Recommendations: 1
Sell Recommendations: 0
Price Target: 59.22
Upside from Last Price: 90.73%

Major Shareholders

  • How many TARS shares are owned by institutional investors?
    57.5M TARS shares are owned by institutional investors
  • How many TARS shares are owned by insiders?
    1.7M TARS shares are owned by insiders